secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001213900-24-003047
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical receives Nasdaq non-compliance notice over independent director shortfall after resignation
--------------------------------------------------------------------------------

- Frank Fischer resigned from Board and all committees effective Nov 30, 2023, causing non-compliance.
- Board now has 6 directors, only 3 independent; Audit Committee has 2 of 3 needed, Compensation Committee 1 of 2.
- Cure period runs until earlier of next annual meeting or Nov 30, 2024; if annual meeting before May 28, 2024, compliance due May 28, 2024.
- Company intends to appoint one or more independent directors to fill vacancies during cure period.
- Notice has no immediate effect on listing or trading of common stock or warrants on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390024003047/0001213900-24-003047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390024003047/ea191545-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-003047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer